MedTrace Logo

Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia

NCT00913107 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2010-06-29

No results posted yet for this study

Summary

The purpose of this study was to determine the efficacy and safety of lamotrigine in patients with trigeminal neuralgia (TGN).

Conditions

  • Trigeminal Neuralgia

Interventions

DRUG

Lamictal®

The regime of prescription for Lamictal® during the clinical trials was as follows: 1. 50 mg twice daily for 10days, followed by, 2. 100 mg twice daily for the next 10days, followed by, 3. 100 mg thrice daily for the next10 days, followed by, 4. 100 mg four times daily for the final 10 days.

DRUG

Tegretol®

The regime of prescription for Tegretol® during the clinical trials was as follows: 1. 150 mg twice daily for 10days, followed by, 2. 200 mg thrice daily for the next 10days, followed by, 3. 300 mg thrice daily for the next 10 days, followed by, 4. 300 mg four times daily for the final 10 days.

Sponsors & Collaborators

  • University of Malaya

    lead OTHER

Principal Investigators

  • Dr. Sameer Shaikh, MDSc. · Faculty of Dentistry, University Malaya

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2008-02-29
Completion
2008-06-30

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00913107 on ClinicalTrials.gov